17.3% of children and adolescents aged 5–19 in the UAE are classified as obese, and 35.8% are overweight. This isn't a rare or isolated issue; it's one of the most common pediatric health concerns in this region, and one of the least properly treated.
A child's weight isn't a reflection of effort, willpower, or parenting. It's frequently connected to genuine metabolic and hormonal factors and left unaddressed, it carries real medical risk: to heart health, joint health, and long-term metabolic function.
This is why our program is led by a pediatric endocrinologist, not structured as a generic weight-loss plan. We look at what's actually happening in your child's body before recommending anything.
For eligible adolescents 12 and older, Wegovy is currently the only FDA-approved GLP-1 medication for pediatric weight management, used under close medical supervision, alongside continued nutritional and psychological support, never as a stand-alone fix.
Results measured under medical supervision, not self-managed at home.
Meet your child's care team
The Metabolic edge
Frequently Asked Questions
Contact Details
Newsletter
